<DOC>
	<DOCNO>NCT01478087</DOCNO>
	<brief_summary>The purpose study evaluate clinical safety feasibility Mysorba patient chronic non-ischemic dilate cardiomyopathy ( DCM ) .</brief_summary>
	<brief_title>Immunoadsorption Therapy Patients With Non-Ischemic Dilated Cardiomyopathy ( DCM )</brief_title>
	<detailed_description />
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>1 . Subject 18 year age old . 2 . Subject provide write informed consent . 3 . Subject classify NYHA Class II III . 4 . Subject diagnose chronic nonischemic dilate cardiomyopathy , define leave ventricular ejection fraction ( LVEF ) &lt; 40 % leave ventricular end diastolic dimension ( LVEDd ) &gt; 55 millimeter ( mm ) LVEDd/BSA &gt; 3.0 cm/m2 . 5 . Subject diagnosed nonischemic dilate cardiomyopathy ≥ 6 month ≤ 5 year prior screen visit . 6 . Subject stable optimal medical therapy , consist ACE inhibitor ( ARB ) , βblocker , diuretic , heart failure least 3 month 7 . Subject physician agree switch subject ACE inhibitor ARB treatment duration . 1 . Subject classify NYHA Class I IV 2 . Subject currently pregnant , lactate , childbearing potential take adequate birth control assess Investigator . 3 . Subject HBV , HCV HIV positive . 4 . Subject anemia , define hemoglobin &lt; 10.0 g/dL . 5 . Subject compromise renal function reflect serum creatinine level &gt; 3.0 mg/dL eGFR &lt; 30 mL/min currently dialysis . 6 . Subject compromise hepatic function measure SGPT ( ALT ) SGOT ( AST ) &gt; three ( 3 ) time upper limit normal . 7 . Subject acute myocarditis ≤ 3 month prior screen visit . 8 . Subject history diameter stenosis &gt; 70 % least one major coronary artery , determine angiography CTA obtain within previous 5 year . 9 . Subject immunosuppressive immunomodulation therapy : intravenous ( IV ) , intramuscular ( IM ) , oral . 10 . Subject history follow preexist heart disease : myocardial infarction ( MI ) , percutaneous coronary intervention ( PCI ) , coronary artery bypass graft ( CABG ) valvular heart disease require repair , replacement , balloon valvuloplasty hypertrophic/restrictive cardiomyopathy constrictive pericarditis 11 . Subject currently participate , ≤ 6 month prior screen visit participate , investigational study new drug , biologic , device . 12 . Subject leave ventricular noncompaction . 13 . Subject leave ventricular assist device ( LVAD ) . 14 . Subject receive heart transplant . 15 . Subject DCM due following : amyloidosis sarcoidosis connective tissue disease peripartum cardiomyopathy alcoholism endocrine dysfunction primary cause DCM prior illicit drug use investigator feel likely cause cardiomyopathy hereditary familial condition ( genetic dilate cardiomyopathy , familial storage disease , Heredofamilial neurologic neuromuscular disease ) 16 . Subject undergone cardiac resynchronization therapy ≤ 6 month prior screen visit . 17 . Subject unable take ARB place ACE inhibitor . 18 . Subject history stroke ≤ 3 month prior screen visit . 19 . Subject currently severe systemic infection require treatment antibiotic . 20 . Subject currently hemodynamic instability define systolic blood pressure &lt; 90 mm Hg without afterload reduction , cardiogenic shock , need inotropic support intraaortic balloon pump . 21 . Subject previously undergone immunosuppressive immunomodulation therapy . 22 . Subject know hypersensitivity contraindication heparin include history heparin induce thrombocytopenia ( HIT ) . 23 . Subject history drug alcohol abuse currently abuse alcohol drug . 24 . Subject active malignancy tumor , noncardiac medical condition , cause life expectancy le one year . 25 . History neutropenia ( WBC &lt; 3,000/mm3 ) , coagulopathy , thrombocytopenia ( platelet count &lt; 100,000/μL ) resolve require treatment past 6 month . 26 . Subject weigh less 40 kg ( 88 lb ) . 27 . Subject require major elective procedure ( AHAdefined intermediate high risk surgery ) within 6 month posttreatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>